Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Biologicals and bone loss.

Krieckaert CL, Lems WF.

Ther Adv Musculoskelet Dis. 2012 Aug;4(4):245-7. doi: 10.1177/1759720X12441275.

2.

How should clinicians manage osteoporosis in ankylosing spondylitis?

Bessant R, Keat A.

J Rheumatol. 2002 Jul;29(7):1511-9. Review.

PMID:
12136913
3.

[Bone mineral density and fracture risk in patients with ankylosing spondylitis].

Madsen OR.

Ugeskr Laeger. 2008 Nov 24;170(48):3956-60. Review. Danish.

PMID:
19087736
4.

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.

Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD.

J Bone Miner Res. 2000 Aug;15(8):1526-36.

7.

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD.

J Bone Miner Res. 2003 Jun;18(6):1051-6.

8.

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

Seibel MJ, Naganathan V, Barton I, Grauer A.

J Bone Miner Res. 2004 Feb;19(2):323-9. Epub 2003 Dec 16.

9.

Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.

Reginster JY, Lecart MP, Richy F.

J Rheumatol Suppl. 2005 Sep;76:21-5.

PMID:
16142847
10.

Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis.

Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD.

Ann Rheum Dis. 1994 Feb;53(2):117-21.

11.

The epidemiology of osteoporosis and fractures in ankylosing spondylitis.

Sambrook PN, Geusens P.

Ther Adv Musculoskelet Dis. 2012 Aug;4(4):287-92. doi: 10.1177/1759720X12441276.

12.

Skeletal morbidity in inflammatory bowel disease.

van Hogezand RA, Hamdy NA.

Scand J Gastroenterol Suppl. 2006;(243):59-64. Review.

PMID:
16782623
13.

Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.

Donaldson MG, Palermo L, Ensrud KE, Hochberg MC, Schousboe JT, Cummings SR.

J Bone Miner Res. 2012 Aug;27(8):1804-10. doi: 10.1002/jbmr.1625.

14.

[Strontium ranelate: a novel concept for the treatment of osteoporosis].

Dimai HP.

Wien Klin Wochenschr. 2005 Nov;117(21-22):728-38. Review. German.

PMID:
16416353
15.

Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma.

Dam TT, Harrison S, Fink HA, Ramsdell J, Barrett-Connor E; Osteoporotic Fractures in Men (MrOS) Research Group.

Osteoporos Int. 2010 Aug;21(8):1341-9. doi: 10.1007/s00198-009-1076-x. Epub 2009 Oct 9.

16.

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.

Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, Spector TD, Brixen K, Goemaere S, Cormier C, Balogh A, Delmas PD, Meunier PJ.

Arthritis Rheum. 2008 Jun;58(6):1687-95. doi: 10.1002/art.23461.

17.

Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.

Fahrleitner A, Prenner G, Kniepeiss D, Iberer F, Tscheliessnigg KH, Piswanger-Sölkner C, Obermayer-Pietsch B, Leb G, Dobnig H.

Wien Klin Wochenschr. 2002 Aug 30;114(15-16):717-24.

PMID:
12602117
18.

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

Reeves HL, Francis RM, Manas DM, Hudson M, Day CP.

Liver Transpl Surg. 1998 Sep;4(5):404-9.

19.

Bone tissue in rheumatoid arthritis (1). Bone mineral density and fracture risk.

Cortet B, Flipo RM, Duquesnoy B, Delcambre B.

Rev Rhum Engl Ed. 1995 Mar;62(3):197-204. Review.

PMID:
7788337

Supplemental Content

Support Center